Hepatic Tumor Global Clinical Trials Review, H2, 2011

Date: December 23, 2011
Pages: 71
Price:
US$ 1,000.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: H7C34CB26D6EN
Leaflet:

Download PDF Leaflet

Hepatic Tumor Global Clinical Trials Review, H2, 2011
Hepatic Tumor Global Clinical Trials Review, H2, 2011

Summary

GlobalData's clinical trial report, “Hepatic Tumor Global Clinical Trials Review, H2, 2011 provides data on the Hepatic Tumor clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatic Tumor. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatic Tumor.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy
  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Introduction
Hepatic Tumor
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Countries Contributing to Clinical Trials in Asia-Pacific
Top Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Hepatic Tumor Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
OXiGENE, Inc.
Clinical Trial Overview of OXiGENE, Inc.
Bayer AG
Clinical Trial Overview of Bayer AG
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Stanford University
Clinical Trial Overview of Stanford University
Tokyo University of Science
Clinical Trial Overview of Tokyo University of Science
Instituto Cientifico y Tecnologico de Navarra
Clinical Trial Overview of Instituto Cientifico y Tecnologico de Navarra
Chiba University Hospital
Clinical Trial Overview of Chiba University Hospital
Yokohama City University Medical Center
Clinical Trial Overview of Yokohama City University Medical Center
Shizuoka General Hospital Respiratory center
Clinical Trial Overview of Shizuoka General Hospital Respiratory center
Osaka Medical College
Clinical Trial Overview of Osaka Medical College
Wake Forest University
Clinical Trial Overview of Wake Forest University
Seoul National University Hospital
Clinical Trial Overview of Seoul National University Hospital
St. Jude Children’s Research Hospital, Inc.
Clinical Trial Overview of St. Jude Children’s Research Hospital, Inc.
The University of Texas Health Science Center at San Antonio
Clinical Trial Overview of The University of Texas Health Science Center at San Antonio
Changhai Hospital
Clinical Trial Overview of Changhai Hospital
Queen's University
Clinical Trial Overview of Queen's University
Tokyo Women's Medical University
Clinical Trial Overview of Tokyo Women's Medical University
Nagoya University
Clinical Trial Overview of Nagoya University
CHU de Besancon
Clinical Trial Overview of CHU de Besancon
Yale University
Clinical Trial Overview of Yale University
Mackay Memorial Hospital
Clinical Trial Overview of Mackay Memorial Hospital
University of Heidelberg
Clinical Trial Overview of University of Heidelberg
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

LIST OF TABLES

Hepatic Tumor Therapeutics Market, Global, Clinical Trials by Zone, 2011*
Hepatic Tumor Therapeutics Market, Global, Clinical Trials by Top Countries, 2011*
Hepatic Tumor Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011*
Hepatic Tumor Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2011*
Hepatic Tumor Therapeutics Clinical Trials, Europe, Top Countries, 2011*
Hepatic Tumor Therapeutics Clinical Trials, North America, Top Countries, 2011*
Hepatic Tumor Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2011*
Hepatic Tumor Therapeutics Clinical Trials, BRIC Countries, 2011*
Hepatic Tumor Therapeutics Clinical Trials, G7 Countries, 2011*
Hepatic Tumor Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2011*
Hepatic Tumor Therapeutics Clinical Trials, E7 Countries, 2011*
Hepatic Tumor Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2011*
Hepatic Tumor Therapeutics Market, Global, Clinical Trials by Phase, 2011*
Hepatic Tumor Therapeutics Market, Global, Clinical Trials In Progress by Phase 2011*
Hepatic Tumor Therapeutics Market, Global, Clinical Trials by Trial Status, 2011*
Hepatic Tumor Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Hepatic Tumor Therapeutics Clinical Trials, Global, Key Sponsors, 2011*
Hepatic Tumor Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011*
Hepatic Tumor Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011*
Hepatic Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by OXiGENE, Inc., 2011*
Hepatic Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2011*
Hepatic Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2011*
Hepatic Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2011*
Hepatic Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Tokyo University of Science, 2011*
Hepatic Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Instituto Cientifico y Tecnologico de Navarra, 2011*
Hepatic Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiba University Hospital, 2011*
Hepatic Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Yokohama City University Medical Center, 2011*
Hepatic Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Shizuoka General Hospital Respiratory center, 2011*
Hepatic Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka Medical College, 2011*
Hepatic Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2011*
Hepatic Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2011*
Hepatic Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Jude Children’s Research Hospital, Inc., 2011*
Hepatic Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas Health Science Center at San Antonio, 2011*
Hepatic Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Changhai Hospital, 2011*
Hepatic Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen's University, 2011*
Hepatic Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Tokyo Women's Medical University, 2011*
Hepatic Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Nagoya University, 2011*
Hepatic Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by CHU de Besancon, 2011*
Hepatic Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2011*
Hepatic Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Mackay Memorial Hospital, 2011*
Hepatic Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Heidelberg, 2011*
Hepatic Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2011*

LIST OF FIGURES

Hepatic Tumor Therapeutics Market, Global, Clinical Trials by Zone (%), 2011*
Hepatic Tumor Therapeutics Market, Global, Clinical Trials by Top Countries, 2011*
Hepatic Tumor Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011*
Hepatic Tumor Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2011*
Hepatic Tumor Therapeutics Clinical Trials, Europe, Top Countries (%), 2011*
Hepatic Tumor Therapeutics Clinical Trials, North America, Top Countries (%), 2011*
Hepatic Tumor Therapeutics Clinical Trials, G7 Countries (%), 2011*
Hepatic Tumor Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2011*
Hepatic Tumor Therapeutics Market, Global, Clinical Trials by Phase (%), 2011*
Hepatic Tumor Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2011*
Hepatic Tumor Therapeutics Market, Global, Clinical Trials by Trial Status, 2011*
Hepatic Tumor Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Hepatic Tumor Therapeutics Clinical Trials, Global, Key Sponsors, 2011*
Hepatic Tumor Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011*
Hepatic Tumor Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011*
GlobalData Methodology
Hepatic Injury Global Clinical Trials Review, Q1, 2011 US$ 1,000.00 Apr, 2011 · 31 pages
Hepatitis B Global Clinical Trials Review, Q2, 2011 US$ 1,000.00 Jun, 2011 · 81 pages
Hepatitis C Global Clinical Trials Review, Q2, 2011 US$ 1,000.00 Jun, 2011 · 84 pages
Hepatitis A Global Clinical Trials Review, Q2, 2011 US$ 1,000.00 Jun, 2011 · 46 pages

Ask Your Question

Hepatic Tumor Global Clinical Trials Review, H2, 2011
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: